Adicet Bio Stock

adicetbio.comHealthcareFounded: 1900Funding to Date: $131MM

Adicet Bio is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.

Register for Details

For more details on financing and valuation for Adicet Bio, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Adicet Bio.

Register Today

Team

Management Team

Carrie Krehlik
Chief Human Resources Officer
Francesco Galimi MD
Chief Medical Officer & Senior Vice President
Brian Hogan
Chief Financial Officer
Aya Jakobovits Ph.D
Founder, Board Member & Senior Advisor
Anil Singhal Ph.D
Chief Executive Officer, President & Board Member
Stewart Abbot Ph.D
Chief Scientific Officer & Chief Operating Officer
Donald Santel
Chairman

Board Members

Asish Xavier Ph.D
Johnson & Johnson Innovation - JJDC
Erez Chimovits
OrbiMed
Michal Silverberg
Novartis Venture Fund
Carl Gordon
Donald Santel
Jonathan Silverstein
Aya Jakobovits Ph.D
Florent Gros
Novartis Venture Fund
Yair Schindel MD
aMoon Fund

Other companies like Adicet Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B